These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16570682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A, Khalid R, Thompson PD.
    J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chelation therapy in cardiovascular disease: an update.
    Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik AJ, Jahangir A.
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
    Elihu N, Anandasbapathy S, Frishman WH.
    J Clin Pharmacol; 1998 Feb; 38(2):101-5. PubMed ID: 9549639
    [Abstract] [Full Text] [Related]

  • 8. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
    Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A.
    Curr Cardiol Rep; 2015 Nov; 17(11):96. PubMed ID: 26364188
    [Abstract] [Full Text] [Related]

  • 9. EDTA chelation therapy meets evidence-based medicine.
    Lamas GA, Hussein SJ.
    Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EDTA chelation therapy in the treatment of vascular disease.
    Chappell LT, Janson M.
    J Cardiovasc Nurs; 1996 Apr; 10(3):78-86. PubMed ID: 8820322
    [Abstract] [Full Text] [Related]

  • 15. Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.
    Peguero JG, Arenas I, Lamas GA.
    Trends Cardiovasc Med; 2014 Aug; 24(6):232-40. PubMed ID: 25106084
    [Abstract] [Full Text] [Related]

  • 16. Chelation trial in patients with cardiovascular disease.
    Yen TH, Yen JS.
    Am Heart J; 2023 Feb; 256():1. PubMed ID: 36336079
    [No Abstract] [Full Text] [Related]

  • 17. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
    Mathew RO, Schulman-Marcus J, Nichols EL, Newman JD, Bangalore S, Farkouh M, Sidhu MS.
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):619-625. PubMed ID: 29129003
    [Abstract] [Full Text] [Related]

  • 18. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
    Ravalli F, Vela Parada X, Ujueta F, Pinotti R, Anstrom KJ, Lamas GA, Navas-Acien A.
    J Am Heart Assoc; 2022 Mar 15; 11(6):e024648. PubMed ID: 35229619
    [Abstract] [Full Text] [Related]

  • 19. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK, Xiao L, Song PA, Xu XX, Liu FY, Sun L.
    Nephrology (Carlton); 2014 Jan 15; 19(1):56-9. PubMed ID: 24341661
    [Abstract] [Full Text] [Related]

  • 20. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    Calderon Moreno R, Navas-Acien A, Escolar E, Nathan DM, Newman J, Schmedtje JF, Diaz D, Lamas GA, Fonseca V.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2931-2941. PubMed ID: 30869793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.